146 related articles for article (PubMed ID: 16004821)
1. [Expression of KAI1/CD82 in neuroblastoma and its correlation to prognosis].
Wu XR; Zhu MH; Zhang ZD
Ai Zheng; 2005 Jul; 24(7):885-9. PubMed ID: 16004821
[TBL] [Abstract][Full Text] [Related]
2. [Expression of Gal-3 and CD82/KAI1 proteins in non-small cell lung cancer and their clinical significance].
Wu SW; Yu L; Zhou L; Cheng ZN; Tao YS
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):124-8. PubMed ID: 23714667
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
4. Frequent low level expression in Ewing sarcoma family tumors and widespread absence of the metastasis suppressor KAI1/CD82 in neuroblastoma.
Aryee DN; Ambros I; Ambros PF; Muehlbacher K; Luegmayr A; Yoshie O; Kovar H
Pediatr Res; 2002 Aug; 52(2):279-85. PubMed ID: 12149507
[TBL] [Abstract][Full Text] [Related]
5. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
[TBL] [Abstract][Full Text] [Related]
6. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
[TBL] [Abstract][Full Text] [Related]
7. [Expression of KAI1, MRP-1, and FAK proteins in lung cancer detected by high-density tissue microarray].
Wang XY; Liu T; Zhu CZ; Li Y; Sun R; Sun CY; Wang AX
Ai Zheng; 2005 Sep; 24(9):1091-5. PubMed ID: 16159431
[TBL] [Abstract][Full Text] [Related]
8. [Role of KAI1 gene expression and loss of heterozygosity of KAI1 in metastatic potential and prognosis of pancreatic cancer].
Fan LX; Shen L; Li JY; Pan KF; Dong B; Zhang Y
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):42-6. PubMed ID: 19489224
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical value of KAI1/CD82 in carcinoma of larynx].
Shu Y; Chen H; Tan Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Dec; 19(23):1065-7. PubMed ID: 16494006
[TBL] [Abstract][Full Text] [Related]
10. Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder.
Ai X; Zhang X; Wu Z; Ma X; Ju Z; Wang B; Shi T
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):79-82. PubMed ID: 17393117
[TBL] [Abstract][Full Text] [Related]
11. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
12. Expression Levels of Tetraspanin KAI1/CD82 in Breast Cancers in North Indian Females.
Singh R; Bhatt ML; Singh SP; Kumar V; Goel MM; Mishra DP; Srivastava K; Kumar R
Asian Pac J Cancer Prev; 2016; 17(7):3431-6. PubMed ID: 27509988
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
[TBL] [Abstract][Full Text] [Related]
14. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S
Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527
[TBL] [Abstract][Full Text] [Related]
15. [Expression of nm23 and KAI1 and their clinical significance in gallbladder adenocarcinoma].
Jiang WX; Song BG; Tang RY; Fang JP
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):441-3. PubMed ID: 19024519
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between the levels of KAI1/CD82 and CD44 and the clinicopathological features of non-small cell lung cancer].
Chen QY; Lin XM; Zhou JY; An Z; Yang L; Jiang ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):101-4. PubMed ID: 14990184
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of CD133 and CD82/KAI1 in bladder urothelial carcinoma and their correlation with vasculogenic mimicry].
Yu L; Wu S; Zhou L; Song W; Wang D
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Sep; 33(9):1336-40. PubMed ID: 24067216
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis.
Zhou XL; Wang M
Genet Mol Res; 2015 Dec; 14(4):17059-67. PubMed ID: 26681053
[TBL] [Abstract][Full Text] [Related]
20. Loss of KAI1/CD82 expression in bone and soft tissue tumors is not associated with lung metastasis.
Arihiro K; Inai K
Pathol Res Pract; 2001; 197(9):627-33. PubMed ID: 11569927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
